Patents by Inventor Fatmire BUJUPI

Fatmire BUJUPI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11851463
    Abstract: The present disclosure provides immunogenic compositions, such as vaccines, including DNA vaccines, and uses thereof, e.g., which include an annexin core domain to mediate efficient antigen delivery and antigen presentation in order to induce an antigen-specific immune response and/or to treat or prevent infectious diseases and/or cancer.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: December 26, 2023
    Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
    Inventors: Fatmire Bujupi, Peter Krammer, Heiko Weyd
  • Publication number: 20210230238
    Abstract: The present disclosure provides immunogenic compositions, such as vaccines, including DNA vaccines, and uses thereof, e.g., which include an annexin core domain to mediate efficient antigen delivery and antigen presentation in order to induce an antigen-specific immune response and/or to treat or prevent infectious diseases and/or cancer.
    Type: Application
    Filed: January 21, 2021
    Publication date: July 29, 2021
    Inventors: Fatmire BUJUPI, Peter KRAMMER, Heiko WEYD
  • Patent number: 10947283
    Abstract: The present disclosure provides immunogenic compositions, such as vaccines, including DNA vaccines, and uses thereof, e.g., which include an annexin core domain to mediate efficient antigen delivery and antigen presentation in order to induce an antigen-specific immune response and/or to treat or prevent infectious diseases and/or cancer.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: March 16, 2021
    Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
    Inventors: Fatmire Bujupi, Peter Krammer, Heiko Weyd
  • Publication number: 20190144513
    Abstract: The present disclosure provides immunogenic compositions, such as vaccines, including DNA vaccines, and uses thereof, e.g., which include an annexin core domain to mediate efficient antigen delivery and antigen presentation in order to induce an antigen-specific immune response and/or to treat or prevent infectious diseases and/or cancer.
    Type: Application
    Filed: June 8, 2017
    Publication date: May 16, 2019
    Inventors: Fatmire BUJUPI, Peter KRAMMER, Heiko WEYD